• (-)-JQ1 Stereoisomer: Redefining Negative Controls in BET Br

  2026-05-02

  Explore the unique properties of (-)-JQ1, the essential JQ1 stereoisomer, and its role as a gold-standard negative control in BET bromodomain research. This article delivers a deep dive into advanced assay design, referencing new mechanistic insights and practical protocols for epigenetics and cancer biology.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-05-02

  This study reveals that lactate-induced lactylation of the small GTPase Ran at lysine 123, controlled by SIRT1, is essential for STAT3 nuclear translocation and A2 astrocyte polarization following oxygen-glucose deprivation/reoxygenation (OGD/R). These findings provide new mechanistic insight into the epigenetic regulation of astrocyte response after CNS injury and suggest new targets for therapeutic intervention.

• Gemcitabine in Cancer Research: Protocols and Optimization

  2026-05-01

  Gemcitabine's precise inhibition of DNA synthesis enables researchers to dissect apoptosis and DNA damage responses in cancer models. This article delivers actionable workflows, troubleshooting insights, and protocol enhancements for maximizing reproducibility in cancer research.

• AP20187: Precision Dimerization for Translational Gene Thera

  2026-04-30

  This thought-leadership article explores how AP20187, a chemical inducer of dimerization, is transforming conditional gene therapy and regulated cell therapy. Blending mechanistic insights with strategic guidance, it highlights the translational power of controlled fusion protein dimerization and contextualizes recent discoveries in signaling regulation, such as the role of 14-3-3 protein interactions in cancer. The article differentiates itself with evidence-based protocol guidance, competitive benchmarking, and a forward-looking perspective on the convergence of mechanistic biology and translational research.

• Doxycycline: Tetracycline Antibiotic Workflows for Cancer Re

  2026-04-30

  Doxycycline transcends its role as a classic tetracycline antibiotic, offering potent metalloproteinase inhibition and antiproliferative activity for cutting-edge cancer and stem cell research. This article breaks down practical workflows, protocol parameters, and troubleshooting strategies to unlock Doxycycline’s full research potential.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-04-29

  NADH (Reduced-form Nicotinamide Adenine Dinucleotide) is central to advanced metabolic assays, powering workflows from mitochondrial function quantification to next-generation photocatalytic cancer therapy. This guide translates recent methodological innovations and troubleshooting insights into actionable parameters for maximizing data quality, reproducibility, and translational impact.

• In Vitro Metrics for Drug Response: Insights for VEGFR Inhib

  2026-04-29

  Schwartz’s dissertation advances in vitro drug response assessment by dissecting the distinct contributions of cell proliferation arrest and cell death to anti-cancer drug efficacy. This methodological innovation clarifies how metrics like relative and fractional viability yield nuanced insights, enabling more precise evaluation of agents such as Tivozanib (AV-951) in oncology research.

• Optimizing Protein Purification with the FLAG tag Peptide (D

  2026-04-28

  The FLAG tag Peptide (DYKDDDDK) streamlines recombinant protein purification and detection with its high solubility, gentle elution, and precise epitope recognition. This article details best-practice workflows, troubleshooting insights, and data-driven parameters to elevate your affinity-based assays.

• ABT-263 (Navitoclax): Potent Bcl-2 Inhibitor for Apoptosis R

  2026-04-28

  ABT-263 (Navitoclax) is a nanomolar-affinity, orally bioavailable Bcl-2 family inhibitor that enables precise dissection of caspase-dependent apoptosis in cancer biology. Its mechanism targets Bcl-2, Bcl-xL, and Bcl-w, making it a key tool in apoptosis assays and resistance modeling. APExBIO supplies validated ABT-263 for research use.

• Cytoskeleton’s Role in Mechanical Stress-Induced Autophagy

  2026-04-27

  This study systematically demonstrates that mechanical stress-induced autophagy in human cells critically depends on cytoskeletal integrity, particularly microfilaments, with microtubules playing a supporting role. The findings clarify mechanotransduction pathways and open directions for targeted manipulation of autophagy in biomedical research.

• Troglitazone: PPARγ Agonist Workflows in Metabolic and Cance

  2026-04-27

  Troglitazone, a dual PPARγ/α agonist, empowers metabolic and oncology researchers to precisely modulate nuclear receptor pathways and interrogate tumor-associated macrophage phenotypes. This guide delivers actionable protocols, troubleshooting insights, and a translation of recent SPP1-targeting breakthroughs for maximizing Troglitazone’s impact.

• ER Stress-Induced Prometastatic States Underlying Metastasis

  2026-04-26

  Conod et al. (2022) elucidate how tumor cells surviving near-lethal stress acquire stable prometastatic phenotypes, termed PAMEs, through ER stress, reprogramming, and cytokine signaling. Their findings clarify the cellular and molecular origin of metastasis and highlight potential intervention points for future therapeutic strategies.

• Y-27632 (SKU B1293): Reliable ROCK Inhibition in Cell Assays

  2026-04-25

  This article delivers a scenario-driven, evidence-based guide for researchers using Y-27632 (SKU B1293) to address common challenges in cell viability and cytoskeletal modulation assays. Drawing on quantitative literature and validated protocols, it demonstrates how APExBIO’s Y-27632 optimizes experimental reproducibility and workflow efficiency for biomedical labs.

• RNAi Screen Reveals Vesicular Transport in SARS-CoV-2 Releas

  2026-04-24

  Kerr et al. performed a comprehensive RNA interference screen in human cells, uncovering vesicle-mediated exocytic transport—particularly Rab11a trafficking—as critical for SARS-CoV-2 release. Their work highlights the potential of targeting host pathways, including CDK9-regulated transport, to inhibit viral egress and inform host-directed antiviral strategies.

• Machine Learning-Guided LNPs for mRNA Immunomodulation in Mi

  2026-04-24

  This study pioneers the integration of supervised machine learning with lipid nanoparticle (LNP) design to optimize mRNA delivery for immunomodulating hyperactivated microglia. By systematically screening LNP variants and leveraging hyaluronic acid modifications, the research demonstrates precise control over microglial phenotypes, with implications for neuroinflammatory disease interventions.

458 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page